Naltrexone and relapse prevention treatment for cocaine-dependent patients

J. M. Schmitz; A. L. Stotts; H. M. Rhoades; J. Grabowski

doi:10.1016/S0306-4603(00)00098-8

Naltrexone and relapse prevention treatment for cocaine-dependent patients

J. M. Schmitz, A. L. Stotts, H. M. Rhoades, J. Grabowski

Research output: Contribution to journal › Article › peer-review

119 Scopus citations

Abstract

A double-blind, placebo-controlled clinical trial examining the joint action of naltrexone (NTX) in combination with relapse prevention (RP) therapy for the treatment of cocaine dependence was conducted. Eighty-five participants who achieved initial abstinence during the intake evaluation and detoxification phase of the study were randomized into 1 of 4 combined NTX (0 vs. 50 mg) by therapy (RP vs. Drug Counseling) experimental conditions for the 12-week outpatient treatment phase of the study. A random effects regression model to test for group differences on percentage of cocaine-positive urines indicated a significant time by medication by therapy interaction, suggesting less cocaine use over time among subjects receiving RP-50mg than those in the other conditions. No differences were found for retention or time until first cocaine-positive urine. Naltrexone was well tolerated by participants, with acceptable rates of medication compliance observed. Treatment integrity measures confirmed successful manipulation of the psychotherapy. These results are consistent with the notion that substance use in dependent patients can be reduced with a combination of coping skills training and pharmacologic treatments.

Original language	English (US)
Pages (from-to)	167-180
Number of pages	14
Journal	Addictive Behaviors
Volume	26
Issue number	2
DOIs	https://doi.org/10.1016/S0306-4603(00)00098-8
State	Published - Mar 4 2001
Externally published	Yes

Bibliographical note

Funding Information:
Support for this research was provided by Grant DA-09262-04 from the National Institute on Drug Abuse, and from the Department of Psychiatry and Behavioral Sciences, University of Texas—Houston. Portions of this work were presented at the 62nd Annual Scientific Meeting of the College on Problems of Drug Dependence, Acapulco, Mexico, 1999. The authors would like to acknowledge the dedicated efforts of the staff at the Treatment Research Clinic of the Substance Abuse Medications Development Research Center, UT—Houston, for their support of this study.

Keywords

Cocaine
Naltrexone
Pharmacotherapy
Psychotherapy
Relapse prevention therapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/S0306-4603(00)00098-8

OpenUrl availability

Full text

Cite this

@article{19b3b3ead0014d248c271be0a2c08a03,

title = "Naltrexone and relapse prevention treatment for cocaine-dependent patients",

abstract = "A double-blind, placebo-controlled clinical trial examining the joint action of naltrexone (NTX) in combination with relapse prevention (RP) therapy for the treatment of cocaine dependence was conducted. Eighty-five participants who achieved initial abstinence during the intake evaluation and detoxification phase of the study were randomized into 1 of 4 combined NTX (0 vs. 50 mg) by therapy (RP vs. Drug Counseling) experimental conditions for the 12-week outpatient treatment phase of the study. A random effects regression model to test for group differences on percentage of cocaine-positive urines indicated a significant time by medication by therapy interaction, suggesting less cocaine use over time among subjects receiving RP-50mg than those in the other conditions. No differences were found for retention or time until first cocaine-positive urine. Naltrexone was well tolerated by participants, with acceptable rates of medication compliance observed. Treatment integrity measures confirmed successful manipulation of the psychotherapy. These results are consistent with the notion that substance use in dependent patients can be reduced with a combination of coping skills training and pharmacologic treatments.",

keywords = "Cocaine, Naltrexone, Pharmacotherapy, Psychotherapy, Relapse prevention therapy",

author = "Schmitz, {J. M.} and Stotts, {A. L.} and Rhoades, {H. M.} and J. Grabowski",

note = "Funding Information: Support for this research was provided by Grant DA-09262-04 from the National Institute on Drug Abuse, and from the Department of Psychiatry and Behavioral Sciences, University of Texas—Houston. Portions of this work were presented at the 62nd Annual Scientific Meeting of the College on Problems of Drug Dependence, Acapulco, Mexico, 1999. The authors would like to acknowledge the dedicated efforts of the staff at the Treatment Research Clinic of the Substance Abuse Medications Development Research Center, UT—Houston, for their support of this study.",

year = "2001",

month = mar,

day = "4",

doi = "10.1016/S0306-4603(00)00098-8",

language = "English (US)",

volume = "26",

pages = "167--180",

journal = "Addictive Behaviors",

issn = "0306-4603",

publisher = "Elsevier Limited",

number = "2",

}

TY - JOUR

T1 - Naltrexone and relapse prevention treatment for cocaine-dependent patients

AU - Schmitz, J. M.

AU - Stotts, A. L.

AU - Rhoades, H. M.

AU - Grabowski, J.

N1 - Funding Information: Support for this research was provided by Grant DA-09262-04 from the National Institute on Drug Abuse, and from the Department of Psychiatry and Behavioral Sciences, University of Texas—Houston. Portions of this work were presented at the 62nd Annual Scientific Meeting of the College on Problems of Drug Dependence, Acapulco, Mexico, 1999. The authors would like to acknowledge the dedicated efforts of the staff at the Treatment Research Clinic of the Substance Abuse Medications Development Research Center, UT—Houston, for their support of this study.

PY - 2001/3/4

Y1 - 2001/3/4

N2 - A double-blind, placebo-controlled clinical trial examining the joint action of naltrexone (NTX) in combination with relapse prevention (RP) therapy for the treatment of cocaine dependence was conducted. Eighty-five participants who achieved initial abstinence during the intake evaluation and detoxification phase of the study were randomized into 1 of 4 combined NTX (0 vs. 50 mg) by therapy (RP vs. Drug Counseling) experimental conditions for the 12-week outpatient treatment phase of the study. A random effects regression model to test for group differences on percentage of cocaine-positive urines indicated a significant time by medication by therapy interaction, suggesting less cocaine use over time among subjects receiving RP-50mg than those in the other conditions. No differences were found for retention or time until first cocaine-positive urine. Naltrexone was well tolerated by participants, with acceptable rates of medication compliance observed. Treatment integrity measures confirmed successful manipulation of the psychotherapy. These results are consistent with the notion that substance use in dependent patients can be reduced with a combination of coping skills training and pharmacologic treatments.

AB - A double-blind, placebo-controlled clinical trial examining the joint action of naltrexone (NTX) in combination with relapse prevention (RP) therapy for the treatment of cocaine dependence was conducted. Eighty-five participants who achieved initial abstinence during the intake evaluation and detoxification phase of the study were randomized into 1 of 4 combined NTX (0 vs. 50 mg) by therapy (RP vs. Drug Counseling) experimental conditions for the 12-week outpatient treatment phase of the study. A random effects regression model to test for group differences on percentage of cocaine-positive urines indicated a significant time by medication by therapy interaction, suggesting less cocaine use over time among subjects receiving RP-50mg than those in the other conditions. No differences were found for retention or time until first cocaine-positive urine. Naltrexone was well tolerated by participants, with acceptable rates of medication compliance observed. Treatment integrity measures confirmed successful manipulation of the psychotherapy. These results are consistent with the notion that substance use in dependent patients can be reduced with a combination of coping skills training and pharmacologic treatments.

KW - Cocaine

KW - Naltrexone

KW - Pharmacotherapy

KW - Psychotherapy

KW - Relapse prevention therapy

UR - http://www.scopus.com/inward/record.url?scp=0035804515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035804515&partnerID=8YFLogxK

U2 - 10.1016/S0306-4603(00)00098-8

DO - 10.1016/S0306-4603(00)00098-8

M3 - Article

C2 - 11316375

AN - SCOPUS:0035804515

SN - 0306-4603

VL - 26

SP - 167

EP - 180

JO - Addictive Behaviors

JF - Addictive Behaviors

IS - 2

ER -

Naltrexone and relapse prevention treatment for cocaine-dependent patients

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this